Muenchener Rueck

Good Q3 results despite high claims

07/11/19 -"• Net profit attributable to shareholders was up by 79% to €865m for Q3 19 • Investment result increased from €1.3bn for Q3 18 to €2.1bn for Q3 19 due to high disposal gains • P&C major-loss ..."

PDF page sample
Pages
46
Language
English
Published on
07/11/19
Download
You may also be interested by these reports :
27/05/20
We have reintegrated the dividend payment (£410m) into our model for 2019. The insurer confirmed its 2022 targets in terms of capital generation ...
27/05/20
Historically, Aviva (Buy, UK) has always underperformed its sector and peers. This trend is not related to the insurer’s capacity to earn money or to ...
26/05/20
We have only refined our figures. Scor released positive Q1 20 figures, with an upward trend in the technical result and in investment income. ...
21/05/20
Net profit was hit by important impairments on investments (€655m) and stood at only €113m. The operating result showed resilience (+7.6% yoy to ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO